Impax Laboratories, Inc. (NASDAQ:IPXL) Stock Quotes and News

Impax Laboratories, Inc. (IPXL) 18.54 -0.33

Price Open:	18.84	Day's Range:	14.41100 - 26.39
Price Close:	18.85	52wk Range:	14.41100 - 27.25
Price Day Change:	-0.33	Volume:	622,384
Price % Change:	-1.75	Market Cap:	1.233B
Bid:	18.12000	PE Ratio:	8.63
Ask:	18.54000	EPS Diluted:	2.184

Trade IPXL NOW!

The Latest On IPXL

Impax, Glaxo Terminate Collaboration for IPX066 4/29/13 8:03am

Impax Pharmaceuticals Announces Presentation of RYTARYTM (IPX066) (Carbidopa and Levodopa) Extended-Release Capsules Phase III and Open-Label Extension Data at the American Academy of Neurology 2013 Annual Meeting 3/19/13 8:02am

Impax Pharma to Present Data from RYTARY Phase III, Open-Laebl Extension Trials at MAAN 3/15/13 8:01am

Mid-Afternoon Market Update: Dow Looks Set to Close at All-Time High, Millennial Media Stumbles 3/5/13 5:22pm

Market Wrap for Tuesday, March 5: Stocks Rally as Dow Closes at New All-Time High 3/5/13 5:20pm

UPDATE: Bank of America Cuts PO to $17 on Impax Laboratories on Persisting FDA Issues 3/5/13 2:11pm

UPDATE: JP Morgan Cut PT on Impax Laboratories Following Disappointing FDA Results 3/5/13 2:10pm

Mid-Day Market Update: Santarus Surges On Earnings Beat, Impax Tumbles 3/5/13 2:00pm

Stocks Hitting 52-Week Lows 3/5/13 11:47am

Morning Market Losers 3/5/13 11:28am

Mid-Morning Market Update: Markets Spike Higher, JC Penney Drops On Stock Sale Report 3/5/13 11:27am

Benzinga's Top Pre-Market Losers 3/5/13 9:11am

Press Releases

Bernstein Liebhard LLP Announces An Investigation Concerning Impax Laboratories, Inc. 6/6/13 Newswire

Impax Laboratories Announces Reduction in Workforce 6/5/13 Business Wire

Impax Laboratories to Present at the Jefferies Global Healthcare Conference 6/3/13 Business Wire

Impax Laboratories to Present at the Deutsche Bank 38th Annual Health Care Conference 5/24/13 Business Wire

Impax Board of Directors Establishes Compliance Committee 5/20/13 Business Wire

Impax Laboratories to Present at the UBS Global Healthcare Conference 5/20/13 Business Wire

Impax Laboratories Launches Authorized Generic of Zomig (zolmitriptan) Tablets and Orally Disintegrating Tablets in the U.S. 5/17/13 Business Wire

Impax Laboratories to Present at the Bank of America Merrill Lynch 2013 Health Care Conference 5/10/13 Business Wire

IMPAX LABORATORIES 96 HOUR ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Lead Plaintiff Motion Deadline in Securities Class Action Lawsuit Against Impax Laboratories, Inc. 5/2/13 Business Wire

Impax Laboratories Reports First Quarter 2013 Results 5/1/13 Business Wire

Impax Pharmaceuticals and GlaxoSmithKline Terminate Their Collaboration on IPX066 (RYTARYTM) 4/29/13 Business Wire

Law Offices of Howard G. Smith Encourages Investors to Inquire About a Lead Plaintiff Position in the Class Action Lawsuit Against Impax Laboratories, Inc. -- IPXL 4/28/13 GlobeNewswire

Get the latest IPXL stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Impax Laboratories, Inc. stock price.

Partner Headlines

Impax Reduces Workforce - Analyst Blog 6/6/13

Impax Launches Generic Zomig - Analyst Blog 5/23/13

Shire Beats Earnings in 1Q - Analyst Blog 5/3/13

Impax Beats Earnings Estimate - Analyst Blog 5/2/13

Glaxo-Impax End Rytary Deal - Analyst Blog 4/30/13

Good News for Warner Chilcott - Analyst Blog 4/15/13

Back to Neutral on Warner Chilcott - Analyst Blog 3/21/13

Impax Laboratories, Inc. (IPXL) CEO Larry Hsu buys 7,000 Shares 3/14/13

Bearish MACD for Impax Laboratories Inc. - Tale of the Tape 3/4/13

Impax Beats on Both Counts - Analyst Blog 3/1/13

Valeant Earnings, Sales Top Estimates; Street Shrugs 2/28/13